Funded Grants

PI Name Organization Title Project Numbersort descending Fiscal Year Major Program/Research Group
Chow, H-H. Sherry University Of Arizona University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet) 1UG1CA242596-01 2019 Lung and Upper Aerodigestive Cancer, Cancer Prevention Clinical Trials Network
Brown, Powel H University Of Tx Md Anderson Can Ctr iCAN-PREVENT: MD Anderson International Cancer Prevention Clinical Trial Consortium 1UG1CA242609-01 2019 Lung and Upper Aerodigestive Cancer, Cancer Prevention Clinical Trials Network
Brenner, Dean E. University Of Michigan At Ann Arbor Early Phase Clinical Cancer Prevention Consortium 1UG1CA242632-01A1 2020 Lung and Upper Aerodigestive Cancer, Cancer Prevention Clinical Trials Network
Khan, Seema Ahsan Northwestern University At Chicago Northwestern Cancer Prevention Consortium 1UG1CA242643-01 2019 Lung and Upper Aerodigestive Cancer, Cancer Prevention Clinical Trials Network
Largaespada, David Andrew University Of Minnesota Recurrent Tumor-Specific Alternately Processed Transcripts as a Source of Neoantigens for NF1-associated Malignant Peripheral Nerve Sheath Tumor Immunoprevention 1UG3CA244687-01 2019 Chemopreventive Agent Development
Altorki, Nasser Khaled Weill Medical Coll Of Cornell Univ Intercepting progression from pre-invasive to invasive lung adenocarcinoma 1UG3CA244697-01 2019 Chemopreventive Agent Development
Frazier, A Lindsay Dana-Farber Cancer Inst Assay Validation of a Circulating miRNA Test for Diagnosis and Monitoring of Malignant Germ Cell Tumors 1UH2CA240688-01 2019 Cancer Biomarkers
Lin, Daniel W. Fred Hutchinson Cancer Research Center Evaluation of commercially available prostate cancer assays to accelerate novel applications in active surveillance 1UH3CA234196-01 2019 Cancer Biomarkers
CHINTHALAPALLY, RAO, UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR In Vivo Evaluation of a Chemopreventive Agent, Ciclesonide, in Mouse Lung Tumor Model by Inhalation 261201200013I-0-26100002-1 2012 PREVENT Cancer Preclinical Drug Development Program
CHINTHALAPALLY, RAO, UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR Characterization of Potential Antigens for Immunization Against Colon Cancer and Testing Multivalent Tumor Vaccines in Min Mice 261201200013I-0-26100003-1 2012 PREVENT Cancer Preclinical Drug Development Program
Davis, Terisa UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR Targeting P2X7 Receptor Antagonists for Prevention of Pancreatic Cancer 261201200013I-0-26100004-1 2013 PREVENT Cancer Preclinical Drug Development Program
Davis, Terisa UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR Development of Muc1 Vaccine for the Prevention of Pancreatic Cancer 261201200013I-0-26100005-1 2013 PREVENT Cancer Preclinical Drug Development Program
Davis, Terisa Ohio State University NSAID Chemoprevention in Colorectal Cancer 261201200020I-0-26100005-1 2013 PREVENT Cancer Preclinical Drug Development Program
Davis, Terisa University of Alabama Evaluation of GLG-302, a STAT3 Antagonist, in the Prevention of Mammary Cancer 261201200021I-0-26100004-1 2013 PREVENT Cancer Preclinical Drug Development Program
Beretta, Laura UNIVERSITY OF TX MD ANDERSON CAN CTR Prevention of Hepatocellular Carcinoma (HCC) Associated with Non Alcoholic Steatohepatitis (NASH) 261201500018I-0-26100007-1 2018 PREVENT Cancer Preclinical Drug Development Program

Pages